A burgeoning number of systematic reviews considering lurasidone in the treatment of bipolar depression have occurred since its Food and Drug Administration extended approval in 2013. While a paucity of available quantitative evidence still precludes preliminary meta-analysis on the matter, the present quality assessment of systematic review of systematic reviews, nonetheless, aims at highlighting current essential information on the topic.
Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews / Fornaro, Michele; De Berardis, Domenico; Perna, Giampaolo; Solmi, Marco; Veronese, Nicola; Orsolini, Laura; Buonaguro, ELISABETTA FILOMENA; Iasevoli, Felice; Köhler, Cristiano André; Carvalho, André Ferrer; DE BARTOLOMEIS, Andrea. - In: BIOMED RESEARCH INTERNATIONAL. - ISSN 2314-6133. - 2017:Epub 2017 May 9(2017). [10.1155/2017/3084859]
Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews
FORNARO, MICHELE;BUONAGURO, ELISABETTA FILOMENA;IASEVOLI, FELICE;DE BARTOLOMEIS, ANDREA
2017
Abstract
A burgeoning number of systematic reviews considering lurasidone in the treatment of bipolar depression have occurred since its Food and Drug Administration extended approval in 2013. While a paucity of available quantitative evidence still precludes preliminary meta-analysis on the matter, the present quality assessment of systematic review of systematic reviews, nonetheless, aims at highlighting current essential information on the topic.| File | Dimensione | Formato | |
|---|---|---|---|
|
BMRI2017-3084859.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Dominio pubblico
Dimensione
1.01 MB
Formato
Adobe PDF
|
1.01 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
